Pain hits harder when your body lacks this specific nutrient.
It’s a strange link, sure. But the data doesn’t lie. Breast cancer patients walking into surgery for a radical mastectomy often walk out with a vitamin D deficiency. And those low numbers? They matter. Specifically, having less than 30 nmol/L seems to crank up the pain dial significantly after the operation.
Preoperative vitamin D supplementation may actually help modulate how much it hurts afterward.
Why does this happen? We don’t fully know. Scientists think it ties into vitamin D’s role in inflammation. Also its impact on the immune system. It regulates how nerves send signals, perhaps? It’s murky, but the connection is growing louder in research circles.
The Experiment
The team at Fayoum University in Egypt watched closely. Between late 2024 and spring 2025, they observed 184 women prepped for breast removal surgery. Half had healthy vitamin D levels, the rest did not. The groups were similar enough—averaging mid-forties in age, similar medical backgrounds. Crucially, the medical staff didn’t know who was deficient. Blinded trials reduce bias, keeping things cleaner.
Standard care applied to everyone. Fentanyl during the cut. IV paracetamol afterward every eight hours. Plus a button for tramadol if it really hurt. Patient-controlled analgesia puts some power back in the hands of the recovering patient, at least momentarily.
Opioid Dependency Spikes
Did they measure pain? Yes. Every six hours for a full day post-surgery. The results were stark. Women with low vitamin D were three times more likely to report moderate to severe pain. Not agonizing screams on a ten-scale, but definitely a grim 4, 5, or 6. It’s the difference between breathing through it and needing heavy chemical assistance.
Then came the drugs.
The deficient group needed more opioids. Just a bit more fentanyl during the procedure—a modest bump of 8 micrograms. Barely a blip. But post-surgery? The gap widened violently. These women used 112mg moretramadol on average than their well-nourished counterparts. That’s a significant extra dose. Tramadol helps, obviously, but it carries risks.
Nausea, dizziness, sedation. Maybe even dependence down the line. The study noted more postoperative sickness in the low-D group too. Vomiting happened only there, statistically speaking. Or at least, that’s where it was reported. The margin was slim, but it points in the same uncomfortable direction.
Not Quite Causal
Correlation is not causation, of course. Always the caveat in observational studies. This happened in one hospital in Egypt. Sample sizes have limits. The researchers didn’t track anxiety or depression or sleep quality. Stress alone can change pain tolerance, after all. Cancer stages varied too, though groups were matched as best they could be.
So we can’t say low vitamin D causes pain directly. Maybe it’s a marker for something else. A weaker immune response. More systemic inflammation we didn’t measure. The study didn’t look at those internal markers. Just the outcome: the pills they took and the pain scores they scribbled down.
Still.
If fixing a vitamin deficiency means avoiding an extra hundred milligrams of tramadol, is it worth trying? The authors think so. They suggest supplementation for those under the 30 nmol/L threshold. It might soften the blow. It might not.
The evidence leans toward yes. But medicine is rarely a simple on/off switch. We tweak doses. We monitor bloodwork. We wait for larger trials to confirm what Egypt saw first. Meanwhile, the women in that hospital felt it immediately. No trial data changes how pain feels in the moment, only what we do next time around.
Perhaps the body just wants what it’s owed. Sunshine, technically. Or a pill that mimics it. Either way, the gap is there. Whether we fill it depends on who is holding the syringe, or the capsule, or the decision.
